市场调查报告书
商品编码
1496727
IVF 设备和耗材市场:按产品、技术类型和最终用户划分 - 全球预测,2024-2030 年IVF Devices & Consumables Market by Product (Accessories & Disposables, Instruments, Reagents & Media), Technology Type (Donor Egg IVF, Fresh Embryo IVF, Frozen Embryo IVF), End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年IVF设备及耗材市场规模将达28.5亿美元,2024年将达33.5亿美元,2030年将达89.1亿美元,复合年增长率为17.64%。
体外受精 (IVF) 设备和用品包括用于支援人工受精过程的各种产品和技术。这包括用于执行卵子取出、精子分离、受精和胚胎培养等程序的设备和耗材,以及用于冷冻保存的储存系统。体外受精设备为细胞增殖提供了一个具有最佳条件的受控环境,这对于在人类体外发育胚胎至关重要。消耗品用于多种目的,包括评估精子活力和受精卵准备。全球不孕症流行显着增加了对体外受精设备和用品的需求。此外,增加研发资金和投资以开发更有效率、侵入性更小的 IVF 技术也显着改善了市场动态。然而,严格的监管核准和频繁的产品召回给製造商带来了重大挑战。此外,胚胎着床前基因检测(PGT)等基因筛检方法的持续发展可以透过选择健康发育机会最高的胚胎来提高体外受精的成功率。这些技术进步正在增加考虑接受体外受精治疗的个人和夫妇的数量,推动市场成长。
主要市场统计 | |
---|---|
基准年[2023] | 28.5亿美元 |
预测年份 [2024] | 33.5亿美元 |
预测年份 [2030] | 89.1亿美元 |
复合年增长率(%) | 17.64% |
区域洞察
在美洲,特别是美国和加拿大,在技术创新、高昂的医疗成本以及由于生活方式因素导致的不孕症普遍存在的推动下,试管婴儿设备和用品市场高度发展。该地区消费者的需求集中在高成功率和先进的不孕症治疗。美国消费者更喜欢具有部分保险覆盖的经济高效的治疗方法,导致对高效且经济实惠的 IVF 耗材的需求很高。在欧洲国家,尤其是欧盟国家,试管婴儿设备及耗材市场成熟,消费者认知度及接受度较高。先进的医疗保健系统和高度的认知度在推动市场方面发挥着重要作用。同时,在中东,文化接受度和不断上升的不孕率正在推动 IVF 市场的成长。然而,严格的法规环境和宗教考虑塑造了市场动态。以色列等国家在技术采用方面发挥重要作用,并制定了鼓励体外受精技术研究的支持政策。此外,由于政府计划生育政策的变化、可支配收入的增加以及不孕率的上升,亚太地区试管婴儿设备和耗材市场正在迅速扩大。消费者越来越多地选择试管受精,当地公司正在大力投资研发,以使技术更容易获得併适合当地需求。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在 IVF 设备和耗材市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 IVF 设备和耗材市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
战略分析和建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在 IVF 设备和耗材市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The IVF Devices & Consumables Market size was estimated at USD 2.85 billion in 2023 and expected to reach USD 3.35 billion in 2024, at a CAGR 17.64% to reach USD 8.91 billion by 2030.
In vitro fertilization (IVF) devices & consumables encompass a range of products and technologies used to assist in the process of artificial fertilization. This includes equipment and supplies utilized to perform procedures such as egg retrieval, sperm isolation, fertilization, and embryo culture, alongside storage systems for cryopreservation. IVF devices provide a controlled environment with optimal conditions for cell growth, which is crucial for developing embryos outside the human body. Consumables are used for various purposes, such as assessing the viability of sperm or the readiness of eggs for fertilization. The prevalence of infertility globally significantly boosts the need for IVF devices & consumables. In addition, enhanced funding and investments in R&D to create more efficient and less invasive IVF technologies significantly enhance market dynamics. However, strict regulatory approval and frequent product recalls present a significant challenge for manufacturers. Moreover, the continual development of genetic screening methods, such as preimplantation genetic testing (PGT), allows for higher success rates of IVF procedures by selecting embryos with the highest potential for healthy development. This technological progression attracts more individuals and couples considering IVF treatments, boosting market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.85 billion |
Estimated Year [2024] | USD 3.35 billion |
Forecast Year [2030] | USD 8.91 billion |
CAGR (%) | 17.64% |
Regional Insights
In the Americas, particularly in the United States and Canada, the IVF devices & consumables market is highly advanced, driven by technological innovation, high healthcare expenditure, and a growing prevalence of infertility due to lifestyle factors. Consumer needs in the region are focused on high success rates and advanced treatments for infertility. American consumers prefer cost-effective treatments due to partial insurance coverage, leading to a high demand for efficient and budget-friendly IVF consumables. In European countries, especially those within the EU, IVF devices and consumables markets are mature, with high consumer awareness and acceptance. Advanced healthcare systems and high awareness play significant roles in driving the market. At the same time, in the Middle East, cultural acceptance and rising infertility rates are pushing the growth of the IVF devices & consumables market. However, heavy regulatory environments and religious considerations shape the market dynamics. Countries, including Israel, are significant in technology adoption and have supportive policies promoting research in IVF technologies. Moreover, APAC's IVF devices and consumables market is expanding rapidly due to changing government policies on family planning, growing disposable incomes, and increasing infertility rates. Consumers are increasingly opting for IVF procedures with regional companies are investing heavily in R&D, making technologies more accessible and adapted to local needs.
Market Insights
The market dynamics represent an ever-changing landscape of the IVF Devices & Consumables Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the IVF Devices & Consumables Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the IVF Devices & Consumables Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Vitrolife AB Enhances IVF Clinical Management through Strategic Acquisition of eFertility
Vitrolife AB has strategically expanded its portfolio in the IVF sector by acquiring eFertility, which is aimed at improving IVF clinic operations. With this acquisition, Vitrolife aims to construct a comprehensive end-to-end platform that incorporates all aspects of the IVF process, promising a leap towards more efficient and integrated clinic management globally. [Published On: 2024-05-02]
Pioneering Partnership in IVF Technology: GenEmbryomics Joins Forces with Progenesis for Advanced Embryo Screening
GenEmbryomics has forged a strategic partnership with Progenesis to enhance IVF treatments through advanced genetic screening. The collaboration revolves around the integration of GenEmbryomics' innovative Panacea-GenomeScreen PGT-WGS test into Progenesis's services, offering comprehensive screening for over 2500 serious genetic disorders to IVF patients. This test, applicable to standard IVF and intracytoplasmic sperm injection (ICSI) embryos, aims to improve IVF success rates by ensuring higher testing accuracy, which may also lead to reduced costs for patients. [Published On: 2024-04-30]
Advancements in IVF Storage Solutions: Introducing TMRW's CryoLink for Enhanced Digital Specimen Management
TMRW Life Sciences unveiled CryoLink, a versatile new workstation that integrates digital management into frozen specimen inventory systems in IVF laboratories. This launch signifies a strategic expansion of TMRW's Digital Specimen Management system, previously accessible only through the company's automated storage platforms. CryoLink offers a less resource-intensive option by allowing clinics to interface with existing storage systems or TMRW's proprietary solutions, including the CryoRobot Select, an FDA-cleared automated storage system known for its robust safety features. [Published On: 2024-03-19]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the IVF Devices & Consumables Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the IVF Devices & Consumables Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Astec Co., Ltd., Becton, Dickinson and Company, Biopsybell S.R.L., DSS Imagetech Pvt. Ltd., Eppendorf SE, Esco Micro Pte. Ltd., Fujifilm Irvine Scientific, Inc., Genea Biomedx Pty Ltd., Gynotec B.V., Hamilton Thorne Inc. by Hamilton Thorne Ltd. Group, Hunter Scientific Limited, Kitazato Corporation, LABOTECT GmbH, LABOX, spol. s r.o., Manina Medtech S.L., Merck KGaA, Nidacon International AB, Overture Life, PHC Holdings Corporation, Rocket Medical PLC by Roko, Shivani Scientific Industries Pvt. Ltd., Smiths Group PLC, The Cooper Companies, Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.
Market Segmentation & Coverage